CD4 and breast cancer: Using Philips signaling pathway analysis, we provided evidence that soluble factors in primary breast cancer tissue induce an immune-tolerant CD4+ T cell state, likely caused by activated immune-suppressive Treg cells that may already be detectable in blood samples.